Engineered Cell Lines vs. Cancer Cell Lines for Conventional Antibody-Drug Conjugate (ADC) Cell-Based Potency Assay Development
Time: 4:45 pm
day: Day One
Details:
- Testing ADC potency through cytotoxicity assays, evaluating the tumor-killing activity of the payload following antibody internalization
- Ensuring assay robustness and specificity through the selection of a target antigen-expressing cell line
